Evolus
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Evolus and other ETFs, options, and stocks.About EOLS
Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau.
CEODavid Moatazedi
CEODavid Moatazedi
Employees332
Employees332
HeadquartersNewport Beach, California
HeadquartersNewport Beach, California
Founded2012
Founded2012
Employees332
Employees332
EOLS Key Statistics
Market cap489.71M
Market cap489.71M
Price-Earnings ratio-8.08
Price-Earnings ratio-8.08
Dividend yield—
Dividend yield—
Average volume2.62M
Average volume2.62M
High today$7.59
High today$7.59
Low today$7.16
Low today$7.16
Open price$7.31
Open price$7.31
Volume456.71K
Volume456.71K
52 Week high$17.12
52 Week high$17.12
52 Week low$5.71
52 Week low$5.71
Stock Snapshot
With a market cap of 489.71M, Evolus(EOLS) trades at $7.56. The stock has a price-to-earnings ratio of -8.08.
During the trading session on 2025-11-14, Evolus(EOLS) shares reached a daily high of $7.59 and a low of $7.16. At a current price of $7.56, the stock is +5.5% higher than the low and still -0.5% under the high.
Trading volume for Evolus(EOLS) stock has reached 456.71K, versus its average volume of 2.62M.
The stock's 52-week range extends from a low of $5.71 to a high of $17.12.
The stock's 52-week range extends from a low of $5.71 to a high of $17.12.
EOLS News
TipRanks 4d
Evolus, Inc. Earnings Call Highlights Growth and ResilienceEvolus, Inc. ((EOLS)) has held its Q3 earnings call. Read on for the main highlights of the call. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst...
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
14.3%
Sell
0%
People also own
Based on the portfolios of people who own EOLS. This list is generated using Robinhood data, and it’s not a recommendation.